Sterol analysis identified four Candida albicans erg3 mutants in which ergosta 7,22-dienol, indicative of perturbations in sterol ⌬ 5,6 -desaturase (Erg3p) activity, comprised >5% of the total sterol fraction. The erg3 mutants (CA12, CA488, CA490, and CA1008) were all resistant to fluconazole, voriconazole, itraconazole, ketoconazole, and clotrimazole under standard CLSI assay conditions (MIC values, >256, 16, 16, 8, and 1 g ml ؊1 , respectively). Importantly, CA12 and CA1008 retained an azole-resistant phenotype even when assayed in the presence of FK506, a multidrug efflux inhibitor. Conversely, CA488, CA490, and three comparator isolates (CA6, CA14, and CA177, in which ergosterol comprised >80% of the total sterol fraction and ergosta 7,22-dienol was undetectable) all displayed azole-sensitive phenotypes under efflux-inhibited assay conditions. Owing to their ergosterol content, CA6, CA14, and CA177 were highly sensitive to amphotericin B (MIC values, <0.25 g ml ؊1 ); CA1008, in which ergosterol comprised <2% of the total sterol fraction, was less sensitive (MIC, 1 g ml ؊1 ). CA1008 harbored multiple amino acid substitutions in Erg3p but only a single conserved polymorphism (E266D) in sterol 14␣-demethylase (Erg11p). CA12 harbored one substitution (W332R) in Erg3p and no residue changes in Erg11p. CA488 and CA490 were found to harbor multiple residue changes in both Erg3p and Erg11p. The results suggest that missense mutations in ERG3 might arise in C. albicans more frequently than currently supposed and that the clinical significance of erg3 mutants, including those in which additional mechanisms also contribute to resistance, should not be discounted.
Many of the compounds used to treat fungal infections including Candida albicans target membrane components central to cell viability and/or the proteins needed for their synthesis. For example, azole antifungals inhibit the activity of sterol 14␣-demethylase (Erg11p) and thus the biosynthesis of fungal ergosterol (Fig. 1) . Ergosterol maintains the integrity and fluidity of cell membranes (1) and consequently is understood to affect the morphology (20) , virulence (30) , and resistance characteristics of fungal pathogens. Following extensive use, resistance to antifungal azoles first emerged in HIV-positive patients (29, 31) ; resistant isolates are now isolated from other clinical settings, including chemotherapy and organ transplantation. Multiple mechanisms govern resistance to azole antifungal agents in C. albicans (6, 26, 28, 36, 38) , and the importance of drug efflux transporters (10, 29, 31) and alterations in the protein target Erg11p (CYP51) (12, 15, 17, 27, 37) are among the most intensively studied.
Traditionally, polyene agents (e.g., amphotericin B [AMB]) that intercalate directly with ergosterol, resulting in membrane leakage and cell death (4, 25) , have provided a treatment alternative for clinicians who encounter azole-resistant candidiasis. However, a molecular mechanism, first described in Saccharomyces cerevisiae (34, 35) , that enables fungal cells to circumvent the inhibitory action of polyenes and azoles through erg3 mutation has also been reported in C. albicans (13, 14, 24) . Briefly, ERG3 mutations that nullify the function of sterol ⌬ 5,6 -desaturase result in accumulation of 14␣-methylfecosterol rather than 14␣-methylergosta-8,24(28)-dien-3␤,6␣-diol following azole inhibition of Erg11p (11) . This, together with a lack of membrane ergosterol, enables C. albicans erg3 mutants to withstand both azole and polyene treatment. Recently, studies have questioned the clinical relevance of mutations in ERG3 (21) , with work in mouse models leading to the conclusion that loss of Erg3p activity attenuates virulence in C. albicans (3) and that this could explain why erg3 mutants are rarely seen in the clinic. However, it is arguably the undetected erg3 mutants that do persist in the clinical setting that warrant greater consideration.
Here, we identify four clinically isolated C. albicans erg3 mutants using gas chromatography-mass spectrometry (GC-MS) sterol analysis. Unlike research studies that focus on specific genes (e.g., ERG11) involved in ergosterol biosynthesis (Fig. 1) , sterol analysis can identify perturbations in the functionality of many ergosterol biosynthetic proteins (here, we focus on sterol ⌬ Our results indicate that strains harboring mutations in ERG3 may be more prevalent than currently supposed and that, in addition to mutants exhibiting total loss of Erg3p activity, leaky mutants should also be considered.
MATERIALS AND METHODS
Strains and media. The isolates (CA6, CA12, CA14, CA177, CA488, CA490, and CA1008) described in this study were identified from a collection of Ͼ100 clinical specimens (O. Bader, M. Kuhns, C. M. Martel GC-MS sterol analysis. Single colonies were used to inoculate 15-ml volumes of RPMI to achieve overnight cultures (18 h; 37°C; 180 rpm) that all exhibited hyphal growth morphology. Cells were harvested by centrifugation and washed with sterile water prior to sterol extraction using a previously optimized methodology (19) . In addition to the analysis of untreated RPMIgrown cultures, the sterol composition of all isolates, following treatment with final concentrations of fluconazole (FLC) and voriconazole (VOR) equivalent to half the minimum concentration required to inhibit growth (0.5ϫ MIC), were also determined. Sterol extracts were evaporated to dryness using a centrifugal evaporator (Heto Maxi Dry Plus) and derivatized [N,O-bis(trimethylsiyl)trifluoroacetamide-trimethylchlorosilane (90:10) plus 50 l anhydrous pyridine] at 70°C for 2 h. Trimethylsilyl (TMS)-derivatized sterols were analyzed using a 7890A GC system (Agilent Technologies) and identified with reference to retention times and fragmentation spectra for known standards. A DB-5MS fused silica column (30 m by 0.25 mm by 0.25-m film thickness) was used for all GC separations (J&W Scientific). The initial oven temperature was held at 70°C for 4 min, followed by ramping (25°C/min) to a final temperature of 280°C; this temperature was held for 25 min. Samples were analyzed in splitless mode (1 l injection volume) using helium carrier gas and electron impact ionization (ion source temperature, 150°C) and scanning from 40 to 850 atomic mass units. GC-MS data files were analyzed using Agilent software (MSD Enhanced ChemStation) to generate sterol profiles and for derivation of integrated peak areas.
Antifungal susceptibility assays. The susceptibilities of CA6, CA12, CA14, CA177, CA488, CA490, and CA1008 to FLC, VOR, itraconazole (ITC), ketoconazole (KTC), clotrimazole (CLT), and AMB were determined using the standardized CLSI M27-A2 broth dilution method (23) and previous interpretive breakpoints (19) : (i) FLC, Յ8 g ml
Ϫ1
, sensitive, and Ն64 g ml
, sensitive, and Ն4 g ml Ϫ1 , resistant; (iii) ITC and KTC, Յ0.125 g ml
, sensitive, and Ն1 g ml Ϫ1 , resistant; (iv) CLT, Ն0.5 g ml Ϫ1 , resistant; and (v) AMB, Յ1 g ml Ϫ1 , sensitive. Assays for susceptibility to FLC and VOR were also performed in the presence of a fixed concentration (10 M) of the putative multidrug efflux inhibitor FK506 (19) . Azole MIC's were determined as the minimum drug concentration yielding at least 80% inhibition of growth compared with the growth of control wells. The MIC for AMB was defined as the lowest drug concentration at which growth was completely inhibited. All assays were performed in triplicate.
PCR. The full-length ERG3 and ERG11 genes were amplified from genomic DNA (single-colony extraction: 0.2% SDS; 90°C; 10 min) using gene-specific forward (F) and reverse (R) primers: ERG3F, 5Ј-GATCATAACTCAATATG G-3Ј; ERG3R, 5Ј-CTGAACACTGAATCG-3Ј; ERG11F, 5Ј-ATGGATATCGT ACTAGAA-3Ј; ERG11R, 5Ј-TCATTGTTCAACATATTC-3Ј. DNA reads were translated into amino acid sequences and aligned with C. albicans ERG3 and ERG11 reference proteins (UniProtKB/Swiss-Prot accession no. O93875 and P10613, respectively).
Cell morphology. The morphologies of all isolates were examined during growth on YEPD agar and 6 or 24 h following transfer of single colonies to liquid RPMI (37°C; 180 rpm).
RESULTS
Sterol profiles of study isolates. Untreated CA6, CA14, and CA177 (Table 1 , untreated) all exhibited normal sterol profiles in which ergosterol comprised Ͼ80% of the total cellular sterol fraction. No sterol intermediates indicative of perturbations in sterol ⌬ 5,6 -desaturase (Erg3p) function (Fig. 1A) were detected in any of these isolates. Conversely, while ergosterol was also detected in untreated CA12, CA488, and CA490, episterol, ergosta 7-enol, and ergosta 7,22-dienol comprised over 40% of the total sterol fraction (Table 1, untreated). In CA1008, ergosta 7,22-dienol comprised Ͼ70% of the sterol fraction with ergosterol never comprising Ͼ2% of the total. Neither 14␣-methyl fecosterol nor 14␣-methylergosta-8,24 (28)-dien-3␤,6␣-diol (here called 14␣-methyl-3,6-diol) were detected in any sterol preparations from untreated isolates.
Azole treatments with FLC and VOR concentrations equivalent to half those required for MIC data ( Table 2 , standard azole MIC assay) altered the sterol compositions of all study isolates (Fig. 2) . The accumulation of 14␣-methylated sterols was observed (especially 14␣-methyl-3,6-diol under VOR treatment) following azole treatment of CA6, CA14, and CA177. This is consistent with azole inhibition of sterol 14␣-demethylase (Erg11p) activity concomitant with functional sterol ⌬ 5,6 -desaturase activity, resulting in 14␣-methyl-3,6-diol formation. Conversely, 14␣-methylfecosterol accumulated (comprising Ͼ55% of the total sterol fraction following FLC and VOR treatment of CA12, CA488, CA490, and CA1008) ( Table 1 , FLC and VOR treated). Detectable amounts of ergosterol and 14␣-methyl-3,6-diol were found in CA488 and CA490; however, negligible amounts were seen in CA12, and neither sterol was detected in azole-treated CA1008. In this respect, CA12 and CA1008 might be described as "classical" erg3 mutants.
Antifungal susceptibilities of study isolates. CA6, CA12, CA177, CA488, CA490, and CA1008 were resistant to azole antifungals under standard assay conditions (MICS, Ն256, 16, 16, 8, and 1 g ml Ϫ1 for FLC, VOR, ITC, KTC, and CLT, respectively); CA14 was the only isolate found to be sensitive ; the suspected erg3 mutants displayed various degrees of sensitivity. CA488 and CA490 were most sensitive (AMB MIC for both, 0.25 g ml Ϫ1 ), followed by CA12 and CA1008 (AMB MICS, 0.5 and 1 g ml Ϫ1 , respectively). ERG3 and ERG11 sequencing. No amino acid substitutions were identified in the ERG3 or ERG11 protein translations for CA6, CA14, or CA177. In contrast, the suspected erg3 mutants (all except CA12) harbored multiple amino acid substitutions in Erg3p, with T330A and A351V substitutions recurring several times (Table 3) . A single-residue change (W332R) was observed in CA12 Erg3p. Five residue substitutions were found in CA1008 Erg3p. Aside from CA12 (no Erg11p alterations), all of the erg3 mutant isolates harbored one or more residue substitutions in Erg11p (Table 3) .
Morphological observations. There were no clear differences between the cell morphologies of any of the study isolates following culture at 37°C (Fig. 3) . All exhibited yeast-like growth on YEPD agar (Fig. 3A) . Following transfer to RPMI, pseudohyphae were observed in all cultures after 6 h (Fig. 3B) , with extensive hyphal growth seen after 24 h (Fig. 3C) .
DISCUSSION
The results presented here focus specifically on the resistance phenotypes of four clinically isolated erg3 mutants. They provide a further demonstration of the proposed mechanism (14) through which "classical" erg3 mutants are able to persist under azole and polyene treatments in the clinic (13, 14, 24) and highlight the fact that fuller understanding of "leaky" erg3 mutants, particularly those in which additional (e.g., drug efflux) mechanisms contribute to resistance, is now required. Clearly, just as no one resistance mechanism can explain azole resistance in C. albicans (6, 26, 28, 37) , no mechanism (e.g., ERG3 mutation) should be disregarded. That CA12 and CA1008 are classical erg3 mutants (with negligible and undetectable sterol ⌬ 5,6 -desaturase activity, respectively) is clear from GC-MS sterol chromatograms. Briefly, in untreated CA1008 (Fig. 2B, boldface trace) , the high relative abundance of ergosta 7,22-dienol (Ͼ70% of the total sterol fraction) and low abundance of ergosterol (Ͻ2% of the total) are indicative of sterol 14␣-demethylase (Erg11p) functionality but defective Erg3p activity (Fig. 1A) . Following azole inhibition of Erg11p, 14␣-methylated sterols (specifically 14␣-methylfecosterol) accumulate in CA1008; this, in addition to the complete absence of 14␣-methyl-3,6-diol (or ergosterol), is again consistent with perturbation of Erg3p functionality and continued growth in the presence of azole.
Because azole-treated CA1008 and CA12 were able to persist despite possessing negligible or no (below GC-MS detection limits) cellular ergosterol (Table 1 , FLC and VOR treated), our results provide further evidence to suggest that it is the formation of 14␣-methyl-3,6-diol (not depletion of cellular ergosterol per se) that is central to the mode of action of azole compounds against C. albicans (11). Furthermore, the fact that CA12 and CA1008 both remained highly resistant to FLC and VOR (withstanding concentrations of Ͼ256 and Ͼ16 g ml Ϫ1 of each azole, respectively), even following inhibition of multidrug efflux transporters (Table 2, 10 M FK506), indicated the underlying importance of their erg3 mutant phenotype. It is noteworthy that a polyene-resistant C. albicans erg5 mutant in which cellular ergosterol was not detectable has recently been reported (19) . The lack of cellular ergosterol in CA12 and CA1008 provides some explanation as to why both were able to tolerate relatively high concentrations of AMB (MICs, 0.5 and 1.0 g ml Ϫ1 , respectively). It has been shown that leaky erg3 mutants of S. cerevisiae can be isolated as fluconazole-resistant strains (9) . Sterol chromatograms for CA488 and CA490 (profiles not shown) indicate that they might be regarded as leaky erg3 mutants in which sterol ⌬ 5,6 -desaturase retains greater activity and thus ergosterol (and 14␣-methyl-3,6-diol following azole inhibition of Erg11p) is detectable in higher abundance (Table 1 , FLC and VOR treated). As in S. cerevisiae, it is possible that, owing to slight perturbation of Erg3p activity, accumulation of 14␣-methylfecosterol enhances the ability of CA488 and CA490 to survive under azole treatment. However, the results from this study indicate that (like CA6 and CA177), drug efflux mechanisms (29, 31 ) also contribute to the azole resistance phenotypes of CA488 and CA490. Given its azole-sensitive phenotype and a lack of evidence for significant drug efflux in CA14 (Table 2, FK506) , the results suggest that better understanding of the molecular bases of drug efflux transport in C. albicans could assist in the identification of new drug targets and thus in the development of novel antifungal agents.
Sequence data for the ERG3 and ERG11 genes in CA1008 and CA12 challenge the suggestion that mutations in ERG3 cannot cause resistance by themselves (21) . While five amino acid substitutions were identified in CA1008 Erg3p, only a single-residue change (E266D) was recorded in the Erg11p sequence. This substitution is a conserved polymorphism in the G helix of C. albicans sterol 14␣-demethylase (2) and was also seen in CA488 and CA490 (this study). E266D may exist in susceptible strains and is currently not understood to confer resistance (16, 17, 39) . The fact that no amino acid substitutions were identified in the Erg11p sequence for CA12, the only isolate to harbor a single substitution (W332R) in Erg3p (Table 3) , underscores this point. It is possible that the tryptophan residue at position 332 in CA12 is important for Erg3p function; modeling and site-directed mutagenesis studies are now required to enhance understanding of Erg3p structure and catalytic domains.
Sequence data for CA488 and CA490 indicate that both harbor multiple-residue changes in Erg3p, including A351V (also seen in CA1008 Erg3p). This variation has been reported previously in a C. albicans wild-type strain, B311 (22) , and thus may not have a deleterious effect on Erg3p function. The additional Erg3p changes in CA488 and CA490 (H243N, T330A, and D147G) were not seen in any other isolates and now warrant further investigation. It should be noted that although the Erg3p substitutions observed in CA488 and CA490 do not result in classical erg3 mutant phenotypes, there is still value in indentifying both missense and nonsense mutations in ERG3, not least because of the potential for development of genetic screening tools that could help clinicians diagnose (and thus treat) problem C. albicans infections more readily. In this respect, it is also significant that several of the CA14  CA177  CA12  W332R  CA488  H243N, T330A, A351V D225G, E266D, E391G, V488I  CA490  D147G, T330A, A351V F72S, T229A, E266D, N440S,  V488I, R523G  CA1008 K97E, L193P, (33) . The investigation of these substitutions and the previously undocumented R523G (CA490 Erg11p) constitutes a potential avenue for future research.
Aside from genotypic and sterol data, it is noteworthy that morphological examination of all of the isolates revealed no obvious differences in their abilities to form hyphae (Fig. 3) . The ability to switch between yeast-like and hyphal growth is understood to be a potential virulence factor in C. albicans (30) . Studies have reported that C. albicans erg3 mutants are impaired in the ability to form filaments (3, 21) , possibly because they lack the ergosterol-rich rafts that are associated with the leading edges of developing hyphae (20) . In this study, the extensive hyphal growth of all isolates (particularly CA1008) suggested that it is possible to maintain this pathogenicity factor while exhibiting defective Erg3p activity. The fact that the evolution of the ergosterol pathway conferred a selective advantage is reflected in the increased survival of wild-type strains over erg mutants when exposed to osmotic stress. The pathway of sterol biosynthesis most likely evolved with the addition of sequential steps, providing an evolutionary advantage to the ancestor of fungi. Hence, molecular properties, such as retention of a 14␣-methyl group in the first sterol, lanosterol, is not necessarily inconsistent with growth (as for 14␣-methylfecosterol), and this has been demonstrated in S. cerevisiae (7) . The existence of erg3 mutants such as those reported here presumably does reflect selective pressure, most likely exposure to antifungal drugs.
Research has investigated how sterol modifications, specifically those in erg3 mutants, might mechanically influence the membrane properties and viability of fungal cells (1) . Of additional interest are findings that suggest cells adjust their membrane compositions in response to sterol perturbations by preferentially changing the sphingolipid composition (8) . Further studies of the membrane properties and sterol-lipid and drug-sterol interactions that might contribute to resistance in C. albicans must now be undertaken.
